BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
Ticker SymbolBHST
Company nameBioharvest Sciences Inc
IPO dateAug 05, 2015
CEOSobel (Ilan)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endAug 05
Address1140 - 625 Howe Street
CityVANCOUVER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryCanada
Postal codeV6C 2T6
Phone16046221186
Websitehttps://bioharvest.com/about/
Ticker SymbolBHST
IPO dateAug 05, 2015
CEOSobel (Ilan)
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data